Guidance
Managing chronic asthma
Pharmacological management
Treatment principles
See recommendations on principles of pharmacological treatment in the BTS, NICE and SIGN guideline on asthma.
Inhalers
See recommendations on inhalers in the BTS, NICE and SIGN guideline on asthma.
Environmental impact of inhaler devices
See recommendations on the environmental impact of inhaler devices in the BTS/SIGN British guideline on the management of asthma (SIGN 158).
People 12 years and over
See recommendations on pharmacological management in people aged 12 and over and the summary of pharmacological management in people aged 12 years and over in the BTS, NICE and SIGN guideline on asthma.
See also the Accelerated Access Collaborative consensus pathway on the management of uncontrolled asthma in adults.
Children aged 5 to 11
See recommendations on pharmacological management in children aged 5 to 11 and the summary of pharmacological management in children aged 5 to 11 in the BTS, NICE and SIGN guideline on asthma.
Children under 5
See recommendations on pharmaceutical management in children under 5 and the summary of pharmacological management in children under 5 in the BTS, NICE and SIGN guideline on asthma.
Decreasing maintenance therapy
See recommendations on decreasing maintenance therapy in the BTS, NICE and SIGN guideline on asthma.
Adherence
See recommendations on adherence in the BTS, NICE and SIGN guideline on asthma.
Non-pharmacological management
See recommendations on non-pharmacological management in the BTS/SIGN British guideline on the management of asthma (SIGN 158).